Search research articles
Contact Us
Filters
Showing results (221-230 of 481) with videos related to
Page
of 49
Sort By:
Geriatrics (Basel, Switzerland)
|
March 18, 2020
Frailty Confers High Mortality Risk across Different Populations: Evidence from an Overview of Systematic Reviews and Meta-Analyses
Richard Ofori-Asenso, Ken Lee Chin, Berhe W Sahle, et al.
Pharmacoeconomics
|
August 22, 2023
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis
Jedidiah I Morton, Clara Marquina, Melanie Lloyd, et al.
Diabetes Care
|
May 24, 2021
Projecting the Incidence of Type 2 Diabetes-Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes Treatment
Jedidiah I Morton, Stephen P McDonald, Agus Salim, et al.
Inflammatory Bowel Diseases
|
July 7, 2021
Endoscopic Prediction of Crohn's Disease Postoperative Recurrence
Peter De Cruz, Amy L Hamilton, Kathryn J Burrell, et al.
Journal of Hypertension
|
November 6, 2009
Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis
Clara C Chan, Christopher M Reid, Tai-Juan Aw, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 15, 2014
Using WOMAC Index scores and personal characteristics to estimate Assessment of Quality of Life utility scores in people with hip and knee joint disease
Ilana N Ackerman, Mark A Tacey, Zanfina Ademi, et al.
Transfusion
|
January 14, 2014
Predicting blood loss and transfusion requirement in patients undergoing surgery for musculoskeletal tumors
Philip A Thompson, Deborah May, Peter F Choong, et al.
Pharmacoeconomics
|
June 26, 2020
Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness
Clara Marquina, Ella Zomer, Sandra Vargas-Torres, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
November 23, 2018
Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016
Si Si, Richard Ofori-Asenso, Tom Briffa, et al.
Mycoses
|
November 13, 2019
A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009-2015
Jake C Valentine, C Orla Morrissey, Mark A Tacey, et al.
Page
of 49
Search research articles
Search
Showing results (221-230 of 481) with videos related to
Sort By:
Page
of 49
Geriatrics (Basel, Switzerland)
|
March 18, 2020
Frailty Confers High Mortality Risk across Different Populations: Evidence from an Overview of Systematic Reviews and Meta-Analyses
Richard Ofori-Asenso, Ken Lee Chin, Berhe W Sahle, et al.
Pharmacoeconomics
|
August 22, 2023
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis
Jedidiah I Morton, Clara Marquina, Melanie Lloyd, et al.
Diabetes Care
|
May 24, 2021
Projecting the Incidence of Type 2 Diabetes-Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes Treatment
Jedidiah I Morton, Stephen P McDonald, Agus Salim, et al.
Inflammatory Bowel Diseases
|
July 7, 2021
Endoscopic Prediction of Crohn's Disease Postoperative Recurrence
Peter De Cruz, Amy L Hamilton, Kathryn J Burrell, et al.
Journal of Hypertension
|
November 6, 2009
Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis
Clara C Chan, Christopher M Reid, Tai-Juan Aw, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 15, 2014
Using WOMAC Index scores and personal characteristics to estimate Assessment of Quality of Life utility scores in people with hip and knee joint disease
Ilana N Ackerman, Mark A Tacey, Zanfina Ademi, et al.
Transfusion
|
January 14, 2014
Predicting blood loss and transfusion requirement in patients undergoing surgery for musculoskeletal tumors
Philip A Thompson, Deborah May, Peter F Choong, et al.
Pharmacoeconomics
|
June 26, 2020
Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness
Clara Marquina, Ella Zomer, Sandra Vargas-Torres, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
November 23, 2018
Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016
Si Si, Richard Ofori-Asenso, Tom Briffa, et al.
Mycoses
|
November 13, 2019
A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009-2015
Jake C Valentine, C Orla Morrissey, Mark A Tacey, et al.
Page
of 49